Michael Jandernoa - Perrigo Company Independent Director

PRGO -- USA Stock  

USD 53.28  2.04  3.69%

Mr. Michael J. Jandernoa is an Independent Director of the Company. He served as Perrigos Chief Executive Officer from 1988 to 2000 and as Chairman of the Board from 1991 to 2003. Mr. Jandernoa also previously served in various other executive capacities with Perrigo since 1979. He is a general partner of 42North Partners was a director of Fifth Third Bank West Michigan, a Michigan banking corporation, from 2004 to December 2009 and a director of Steelcase, Inc., a manufacturer of casegood products and furniture systems for the office furniture industry, from 2002 to March 2010. Mr. Jandernoa served on the Board of the Strategic Economic Investment and Commercial Board through early 2011. He currently serves as First Vice Chair of the Business Leaders of Michigan, Inc. Mr. Jandernoa also serves on several private company and nonprofit boards.
Age: 64  Director Since 2007      
353 1 709 4000  http://www.perrigo.com

Michael Jandernoa Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives


Bruce CarterDr Reddys Laboratories Ltd
Frank DAmelioZoetis
Anthony ColesRegeneron Pharmaceuticals
William DoyleZoetis
James KangOrigin Agritech Limited
Terrence KearneyVertex Pharmaceuticals Incorpor
Louise ParentZoetis
Kalpana MorpariaDr Reddys Laboratories Ltd
Elaine UllianVertex Pharmaceuticals Incorpor
Robert ScullyZoetis
Marc TessierLavigneRegeneron Pharmaceuticals
Margaret McGlynnVertex Pharmaceuticals Incorpor
Min TangOrigin Agritech Limited
J MoreauDr Reddys Laboratories Ltd
Anupam PuriDr Reddys Laboratories Ltd
Leo PuriDr Reddys Laboratories Ltd
Fei WangOrigin Agritech Limited
Paul BisaroZoetis
Gregory NordenZoetis
Alan GarberVertex Pharmaceuticals Incorpor
Joseph GoldsteinRegeneron Pharmaceuticals

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Portfolio File Import Now


Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Currently Active Assets on Macroaxis

Purchased few shares of
a day ago
Traded for 188.14
Purchased a lot of shares of
a day ago
Traded for 150.35
Purchased few shares of
a day ago
Traded for 175.29
Purchased a lot of shares of
a day ago
Traded for 152.77
Purchased over 300 shares of
a day ago
Traded for 9.25
Additionally take a look at Your Equity Center. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Search macroaxis.com